Abstract
The generation of genetically altered mice for research is invaluable for investigations into the underlying mechanisms of common complex diseases such as cancer as well as for therapeutic studies. The correct identification of the genotype of each mouse is therefore essential. Genotyping is routinely performed by using blood, tail or ear tissue; however, this can cause pain or discomfort to the animal and nor is amenable to scale up for high-throughput sampling and analyses. Genotyping from saliva, hair and rectal cells is less invasive, but still requires the restraint of the animal. In contrast, collection of stool samples for DNA isolation is non-invasive as well as repeatable and time efficient, with recent studies showing it to be as accurate as the alternative methods. Fecal DNA genotyping therefore provides an attractive technique for non-invasive genotyping. This feature article examines and synthesizes the recent advances in fecal genotyping with a view to mouse models for nutrigenomics cancer chemoprevention studies specifically, and personalized medicine more broadly.
Keywords: Cancer, feces, genotyping, non-invasive, novel diagnostic platforms, personalized medicine, transgenic mice
Current Pharmacogenomics and Personalized Medicine
Title:Fecal DNA Genotyping: A Non-invasive Approach to Characterize Mouse Models for Nutrigenomics Cancer Chemoprevention Studies
Volume: 11 Issue: 1
Author(s): Erin L. Symonds
Affiliation:
Keywords: Cancer, feces, genotyping, non-invasive, novel diagnostic platforms, personalized medicine, transgenic mice
Abstract: The generation of genetically altered mice for research is invaluable for investigations into the underlying mechanisms of common complex diseases such as cancer as well as for therapeutic studies. The correct identification of the genotype of each mouse is therefore essential. Genotyping is routinely performed by using blood, tail or ear tissue; however, this can cause pain or discomfort to the animal and nor is amenable to scale up for high-throughput sampling and analyses. Genotyping from saliva, hair and rectal cells is less invasive, but still requires the restraint of the animal. In contrast, collection of stool samples for DNA isolation is non-invasive as well as repeatable and time efficient, with recent studies showing it to be as accurate as the alternative methods. Fecal DNA genotyping therefore provides an attractive technique for non-invasive genotyping. This feature article examines and synthesizes the recent advances in fecal genotyping with a view to mouse models for nutrigenomics cancer chemoprevention studies specifically, and personalized medicine more broadly.
Export Options
About this article
Cite this article as:
L. Symonds Erin, Fecal DNA Genotyping: A Non-invasive Approach to Characterize Mouse Models for Nutrigenomics Cancer Chemoprevention Studies, Current Pharmacogenomics and Personalized Medicine 2013; 11 (1) . https://dx.doi.org/10.2174/1875692111311010004
DOI https://dx.doi.org/10.2174/1875692111311010004 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Common Themes in RNA Subcellular Transport, Stress Granule Formation and Abnormal Protein Aggregation
Current Chemical Biology Vanilloid Receptor Antagonists: Emerging Class of Novel Anti-Inflammatory Agents for Pain Management
Current Pharmaceutical Design Recent Developments in Deception Research
Current Psychiatry Reviews Antiprotozoal Agents: An Overview
Anti-Infective Agents in Medicinal Chemistry Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design Recent Progress in Anticonvulsant Drug Research: Strategies for Anticonvulsant Drug Development and Applications of Antiepileptic Drugs for Non-Epileptic Central Nervous System Disorders
Current Topics in Medicinal Chemistry Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1
Current Drug Metabolism Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2
Current Protein & Peptide Science Epigenetic Drugs in Cognitive Disorders
Current Pharmaceutical Design MR-Based In Vivo Analysis of Joint Biomechanics and its Relevance in the Pathogenesis of Osteoarthritis
Current Rheumatology Reviews Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Changes in Immune and Endocrine Systems in Scrapie-Infected Animals
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Kounis Syndrome Following Beta-Lactam Antibiotic Use: Review of Literature
Inflammation & Allergy - Drug Targets (Discontinued) Decreased Expression of Sox-1 in Cerebellum of Rat with Generalized Seizures Induced by Kindling Model
CNS & Neurological Disorders - Drug Targets Current and Under Development Treatment Modalities of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Pulmonary Hypertension and Lung Transplantation
Current Hypertension Reviews Sleep Level Prediction for Daytime Short Nap Based on Auto-Regressive Moving Average Model
Neuroscience and Biomedical Engineering (Discontinued) Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report
CNS & Neurological Disorders - Drug Targets Design, Structure Activity Relationships and X-Ray Co-Crystallography of Non-Steroidal LXR Agonists
Current Medicinal Chemistry Osteoarthritis: Aging of Matrix and Cells - Going for a Remedy
Current Drug Targets